
About Koshihikari
Koshihikari is a Healthcare company based in China founded in 2013. AI-based ECG diagnostic systems for cardiovascular disease detection are provided. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Arrhythmia.
Company details
Koshihikari was founded in 2013 in China within the health technology sector. AI-driven ECG diagnostic systems are developed and supplied by the company to identify various cardiovascular conditions. Operations focus on delivering ECG products, specialized diagnostic algorithms, and arrhythmia management solutions. These tools support clinical applications in disease detection and monitoring across medical facilities.
- Headquarters China
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website prudencemed.com
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Koshihikari
Koshihikari was founded in 2013.
Koshihikari is headquartered in China.
Koshihikari was founded in 2013 in China within the health technology sector. AI-driven ECG diagnostic systems are developed and supplied by the company to identify various cardiovascular conditions. Operations focus on delivering ECG products, specialized diagnostic algorithms, and arrhythmia management solutions. These tools support clinical applications in disease detection and monitoring across medical facilities.